Our Thinking

How big is the market for…?

We often are asked the size of the market for various segments of the bio/pharma contract services industry. In response, we’ve developed a resource page that addresses these questions. To learn about the size of these market segments and others…

Trend Reports

Dose CMOs by the Numbers: Composition, Size, Market Share, Profitability and Outlook

PharmSource’s experts explain the relative market shares of solid, semi-solid/liquid/injectable and specialty dose forms. Learn how industry revenues are distributed among bio/pharmaceutical Contract Manufacturing Organizations (CMOs) by size, and…

Blog

What’s Next for the CMO Industry?

Research indicates that contract manufacturing of drug product for developed markets grew 6% annually in 2013 and 2014 to $16.5 billion. The contract manufacturing organization (CMO) industry grew at twice the rate of bio/pharmaceutical industry revenues in…

Lead Sheet

Real-time Expert BD Intelligence

CROs, CMOs and CDMOs worldwide depend on the PharmSource Lead Sheet for fresh leads, up-to-date contact information and reliable market intelligence. Quickly scout well-targeted new business opportunities. Learn more

Strategic Advantage

Proprietary Global Sourcing Intelligence in an Instant

Decision-makers at CMOs, CDMOs and Bio/Pharma companies rely on Strategic Advantage, to understand industry trends and company capabilities. Quickly get hard-to-find information and benefit from PharmSource’s trademark quantitative approach to analysis. Learn more

Market Intelligence

Bio/Pharmaceutical Outsourcing Report:
Early Development Serv- ices Enjoy Strong First Half

Results from the first half of the year highlighted the importance of external fundraising to drive elements of the outsourcing ecosystem. Contract service providers supporting early development, especially those with a strong presence in drug discovery, posted a revenue increase of…